We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRA
2126
DELISTED
ProAssurance
PRA
| $3.19M | ﹤0.01% |
182,364
-41,211
| -18% | -$812K |
|
2127
CNA Financial
CNA
$14.1B
| $3.18M | ﹤0.01% |
75,150
+3,689
| +5% | +$151K |
|
|
SAFE
2128
DELISTED
Safehold Inc.
SAFE
| $3.18M | ﹤0.01% |
110,973
+47,940
| +76% | +$1.37M |
|
2129
Aclaris Therapeutics
ACRS
$869M
| $3.17M | ﹤0.01% |
201,597
-19,827
| -9% | -$319K |
|
2130
National Beverage
FIZZ
$3.01B
| $3.17M | ﹤0.01% |
68,231
-2,488
| -4% | -$117K |
|
2131
Arlo Technologies
ARLO
$1.65B
| $3.17M | ﹤0.01% |
903,172
-431,247
| -32% | -$1.77M |
|
2132
Mesa Laboratories
MLAB
$574M
| $3.16M | ﹤0.01% |
19,031
-223
| -1% | -$34.9K |
|
|
UMH
2133
UMH Properties
UMH
$1.36B
| $3.15M | ﹤0.01% |
195,303
+22,856
| +13% | +$385K |
|
|
FORG
2134
DELISTED
ForgeRock, Inc.
FORG
| $3.14M | ﹤0.01% |
137,830
+50,162
| +57% | +$1.09M |
|
2135
Keros Therapeutics
KROS
$221M
| $3.14M | ﹤0.01% |
65,339
+646
| +1% | +$30.2K |
|
|
VTLE
2136
DELISTED
Vital Energy
VTLE
| $3.13M | ﹤0.01% |
60,885
+14,056
| +30% | +$868K |
|
2137
Clearfield
CLFD
$374M
| $3.13M | ﹤0.01% |
33,239
-1,302
| -4% | -$137K |
|
|
EB
2138
DELISTED
Eventbrite
EB
| $3.12M | ﹤0.01% |
531,748
-106,189
| -17% | -$694K |
|
|
ONL
2139
Orion Office REIT
ONL
$160M
| $3.12M | ﹤0.01% |
364,940
+16,244
| +5% | +$148K |
|
2140
Ennis
EBF
$564M
| $3.11M | ﹤0.01% |
140,206
+54,192
| +63% | +$1.2M |
|
2141
Microvision
MVIS
$78.9M
| $3.1M | ﹤0.01% |
88,038
+1,543
| +2% | +$71.7K |
|
|
UDMY
2142
DELISTED
Udemy
UDMY
| $3.1M | ﹤0.01% |
293,338
+85,711
| +41% | +$1.16M |
|
2143
PC Connection
CNXN
$2.12B
| $3.09M | ﹤0.01% |
65,943
-5,390
| -8% | -$271K |
|
2144
Kymera Therapeutics
KYMR
$8.94B
| $3.09M | ﹤0.01% |
123,785
-15,850
| -11% | -$423K |
|
|
MGI
2145
DELISTED
MoneyGram International, Inc. New
MGI
| $3.09M | ﹤0.01% |
283,573
-41,419
| -13% | -$443K |
|
2146
Warby Parker
WRBY
$3.27B
| $3.08M | ﹤0.01% |
228,064
-12,927
| -5% | -$198K |
|
2147
Energy Transfer Partners
ET
$69.3B
| $3.08M | ﹤0.01% |
259,091
-29,377
| -10% | -$352K |
|
2148
Barrett Business Services
BBSI
$804M
| $3.06M | ﹤0.01% |
131,444
+27,908
| +27% | +$632K |
|
2149
Sonic Automotive
SAH
$2.61B
| $3.06M | ﹤0.01% |
62,148
-12,745
| -17% | -$610K |
|
2150
Liquidity Services
LQDT
$1.32B
| $3.06M | ﹤0.01% |
217,623
-12,622
| -5% | -$203K |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.